Abstract

The severe acute respiratory syndrome coronavirus 2 envelope protein (S2-E) is a conserved membrane protein that is important for coronavirus (CoV) assembly and budding. Here, we describe the recombinant expression and purification of S2-E in amphipol-class amphipathic polymer solutions, which solubilize and stabilize membrane proteins, but do not disrupt membranes. We found that amphipol delivery of S2-E to preformed planar bilayers results in spontaneous membrane integration and formation of viroporin cation channels. Amphipol delivery of the S2-E protein to human cells results in plasma membrane integration, followed by retrograde trafficking to the trans-Golgi network and accumulation in swollen perinuclear lysosomal-associated membrane protein 1–positive vesicles, likely lysosomes. CoV envelope proteins have previously been proposed to manipulate the luminal pH of the trans-Golgi network, which serves as an accumulation station for progeny CoV particles prior to cellular egress via lysosomes. Delivery of S2-E to cells will enable chemical biological approaches for future studies of severe acute respiratory syndrome coronavirus 2 pathogenesis and possibly even development of “Trojan horse” antiviral therapies. Finally, this work also establishes a paradigm for amphipol-mediated delivery of membrane proteins to cells.

Highlights

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a focal point of science and society in 2020

  • These results demonstrate that recombinant SARS-CoV-2 envelope protein (S2-E) can be delivered into preformed lipid bilayers using amphipols, where the protein inserts into the bilayers and retains ion channel function, without compromising the bilayer integrity

  • We have shown that the S2-E protein can be stripped of lipid and detergent and purified into aqueous solutions in which its solubility is maintained solely by complexation with amphipols

Read more

Summary

ACCELERATED COMMUNICATION

Hutchison1,2,‡ , Ricardo Capone2,3,‡ , Dustin D. Sanders2,3,6,* From the 1Chemical and Physical Biology Graduate Program, 2Center for Structural Biology, 3Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA; 4School of Molecular Sciences, 5The Biodesign Institute Centers for Personalized Diagnostics and Mechanisms of Evolution, Arizona State University, Tempe, Arizona, USA; 6Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Edited by Karen Fleming
Results and discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call